标题 |
A multicenter, randomized phase II trial on the efficacy and safety of hetrombopag for the treatment of chemotherapy-induced thrombocytopenia in patients with advanced solid tumors. 2023 European Congress of Internal Medicine, Abstract 2360
一项关于hetrombopag治疗晚期实体瘤患者化疗诱导的血小板减少症的疗效和安全性的多中心、随机II期试验。2023年欧洲内科医学大会,摘要2360
|
网址 |
求助人暂未提供
|
DOI |
暂未提供,该求助的时间将会延长,查看原因?
|
其它 | jun Ma, Yusheng Wang, Jun Yao, et al. |
求助人 | |
下载 |